Liesbet De Bus

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Alexis Tabah, Niccolò Buetti, Quentin Staiquly et al. · Intensive Care Medicine · 2023 · 246 citations · Full text

Veterinary Medicine, Infectious Diseases, Critical Care Medicine +15

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 151 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 137 citations · Full text

Medicine, Critical Care Nursing, Critical Care Medicine +6

Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study

Liesbet De Bus, Pieter Depuydt, Johan Steen et al. · Intensive Care Medicine · 2020 · 116 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Yaseen M. Arabi, Anthony Gordon, Lennie Derde et al. · Intensive Care Medicine · 2021 · 100 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9